Oscar Health, Inc. Class A

Stage 2 · Advancing · week 22

As of Oct 22, 2026, Oscar Health is in Stage 2, the uptrend phase, now in week 22 (since May 21, 2026). It closed at $33.32, 2.9% below its 52-week high and above its 200-day average, which is rising.

Oscar Health, Inc. operates as a healthcare technology company in the United States. More about the company

$33.32

-0.70% today

$10.3B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 5 in Healthcare Plans · #1 of 272 in Health Care

Is OSCR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 30w

S4 15w

S4 16w

S2 22w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 1w → S3 8w → S4 5w → S1 4w → S2 30w → S3 9w → S2 6w → S3 4w → S4 15w → S1 3w → S4 8w → S1 5w → S2 4w → S3 3w → S2 12w → S3 7w → S4 16w → S1 3w → S2 22w current

Total tracked: 165 weeks across 19 stage runs.

OSCR among Healthcare Plans2nd of 11 by relative strength

All 11 →

Stocks in Healthcare Plans ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	CNCCentene Corporation	Stage 2 · wk 1	94	+14.8%
2	OSCROscar Health, Inc. Class A	Stage 2 · wk 22	87	+9.1%
3	PGNYProgyny, Inc.	Stage 3 · wk 7	86	+12.7%
4	CLOVClover Health Investments, Corp. Class A	Stage 2 · wk 2	85	+3.5%
5	HUMHumana Inc.	Stage 2 · wk 2	84	+12.3%
6	ELVElevance Health, Inc.	Stage 2 · wk 6	76	+11.7%
7	UNHUnitedHealth Group Incorporated	Stage 3 · wk 7	69	+14.5%
8	CVSCVS Health Corporation	Stage 3 · wk 7	68	+10.8%

vs 52W High

-2.9%

$10.85 lo$34.32 hi

2.9% below 52W high, pullback range

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 22

1w13w26w

Week 22, proven structure

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

43.7%

200 DMA: $23.19 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.85x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↗

Short-term trend rising gently

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+9.1%

+18.2%

+102.8%

YTD

+122.6%

+53.1%

Scan Membership

Breakout Watch

Latest: 2024-09-17

3 appearances in last 60 days. First seen: 2023-03-31.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 22 · Vol 0.85x

2026-10-21S2

Wk 22 · Vol 0.44x

2026-10-20S2

Wk 21 · Vol 1.12x

2026-10-19S2

Wk 21 · Vol 0.65x

2026-10-16S2

Wk 21 · Vol 1.03x

2026-10-15S2

Wk 21 · Vol 0.91x

2026-10-14S2

Wk 21 · Vol 0.95x

2026-10-13S2

Wk 20 · Vol 0.99x

2026-10-12S2

Wk 20 · Vol 1.06x

2026-10-09S2

Wk 20 · Vol 0.98x

2026-10-08S2

Wk 20 · Vol 0.75x

2026-10-07S2

Wk 20 · Vol 0.98x

Moving averages & range

50 DMA

$31.82

200 DMA

$23.19

52W High

$34.32

52W Low

$10.85

5D Low

$31.89

Resistance levels (recent highs)

20d High

$34.32

60d High

$34.32

120d High

$34.32

250d High

$34.32

Next resistance

+3.0%

to 20d High

P/E (TTM)

25.8

Forward 15.0

ROE

+34.3%

Profit margin +3.6%

Dividend Yield

0.00%

P/B 5.0

Oscar Health: quick answers

What stage is Oscar Health in?

As of Oct 22, 2026, Oscar Health (OSCR) is in Stage 2, the uptrend phase. It entered Stage 2 on May 21, 2026 and is in week 22. What the four stages mean

Is Oscar Health in an uptrend?

Yes. Oscar Health is in a Stage 2 uptrend. It trades 43.7% above its 200-day average, which is rising.

How far is Oscar Health from its 52-week high?

Oscar Health closed at $33.32 on Oct 22, 2026, 2.9% below its 52-week high of $34.32. Its 52-week low is $10.85.

How has Oscar Health performed over the past year?

As of Oct 22, 2026, Oscar Health is up 53.1% over the past year and up 122.6% so far in 2026.

Which sector and industry is Oscar Health in?

Oscar Health is in the Healthcare Plans industry, part of the Health Care sector.

About this companyHealth Care· Healthcare Plans

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.